# Magnesium Blood Pressure Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/magnesium-blood-pressure-meta-analysis-evidence-review
Category: evidence-review
Summary: Magnesium Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are 
Last reviewed: 2026-06-07
Reviewed by: Migaku Evidence Review
# Magnesium Blood Pressure Meta-analysis: What the Evidence Says

## Quick Answer

Magnesium Blood Pressure Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 1 systematic review, 1 narrative review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials | systematic review | 1 | 2026-05-11 | 10.3389/fnut.2026.1738410 |
| Hypomagnesemia: A Clinical and Nutritional Update | narrative review | 3 | 2026-03-24 | 10.1007/s13668-026-00745-5 |

## What The Sources Report

- Metabolic syndrome (MetS), also known as Syndrome X, is a major risk factor for cardiovascular disease worldwide. [Zhao Pengyu (2026); evidence level 1]
- MetS components typically include abdominal obesity, hypertension, dysregulated glucose metabolism, and dyslipidemia (elevated TG levels and reduced HDL-C levels). [Zhao Pengyu (2026); evidence level 1]
- Thus, this review aims to integrate advances in magnesium physiology with contemporary clinical and nutritional evidence, providing a consolidated strategy for understanding the causes, manifestations, diagnosis, and management of hypomagnesemia. [Papagiannidou Anastasia (2026); evidence level 3]
- Finally, we also cover practical laboratory assessment and evidence-informed repletion strategies. [Papagiannidou Anastasia (2026); evidence level 3]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium blood pressure meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Zhao Pengyu (2026). The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1738410. PMCID: PMC13199047. PMID: 42199758. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13199047/
- Papagiannidou Anastasia (2026). Hypomagnesemia: A Clinical and Nutritional Update. DOI: 10.1007/s13668-026-00745-5. PMCID: PMC13009017. PMID: 41872423. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13009017/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.